Cargando…
Molecular basis for drug repurposing to study the interface of the S protein in SARS-CoV-2 and human ACE2 through docking, characterization, and molecular dynamics for natural drug candidates
A novel coronavirus (SARS-CoV-2) identified in Wuhan state of China in 2019 is the causative agent of deadly disease COVID-19. It has spread across the globe (more than 210 countries) within a short period. Coronaviruses pose serious health threats to both humans and animals. A recent publication re...
Autores principales: | Alazmi, Meshari, Motwalli, Olaa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657070/ https://www.ncbi.nlm.nih.gov/pubmed/33175236 http://dx.doi.org/10.1007/s00894-020-04599-8 |
Ejemplares similares
-
Analysis of natural compounds against the activity of SARS-CoV-2 NSP15 protein towards an effective treatment against COVID-19: a theoretical and computational biology approach
por: Motwalli, Olaa, et al.
Publicado: (2021) -
Molecular docking suggests repurposing of brincidofovir as a potential drug targeting SARS-CoV-2 ACE2 receptor and main protease
por: Hussien, Mostafa A., et al.
Publicado: (2020) -
Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations
por: Omer, Samia E., et al.
Publicado: (2022) -
Computational search for drug repurposing to identify potential inhibitors against SARS-COV-2 using Molecular Docking, QTAIM and IQA methods in viral Spike protein – Human ACE2 interface
por: Faria, Sergio H.D.M., et al.
Publicado: (2021) -
Predicting perfect drug candidates: Molecular docking 2.0
por: Nounou, Mohamed Ismail
Publicado: (2014)